Treatment of type 2 inflammation: Targeted therapy for chronic rhinosinusitis with nasal polyps and asthma. Eschenbacher WH. Ann Allergy Asthma Immunol 2024;133:497-498.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Eschenbacher WH. Treatment of type 2 inflammation: Targeted therapy for chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy Asthma Immunol 2024;133:497-498.
PMID: 39488361